Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 1, 2011, Pages 87-90

  Chan, Hiu Ting ^a   So, Lok Tsun ^a   Li, Sheung Wai ^b   Siu, Chung Wah ^a   Lau, Chu Pak ^a   Tse, Hung Fat ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

anticoagulation; atrial fibrillation; diet; herbs; warfarin

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DONG GUAI; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISPAGULA; PLANT MEDICINAL PRODUCT; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CHINESE HERB; DIETARY INTAKE; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; FENUGREEK; FOOD DRUG INTERACTION; GARLIC; GINGER; GINKGO BILOBA; GINSENG; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LYCIUM; MAJOR CLINICAL STUDY; MALE; PAPAYA; PRIORITY JOURNAL; QUESTIONNAIRE; SALVIA MILTIORRHIZA; TEA;

EID: 79960415771     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821cd888     Document Type: Article

References (26)

1. Wyse DG. Anticoagulation in atrial fibrillation: a contemporary viewpoint. Heart Rhythm. 2007;4(suppl 3):S34-S49.
2. Hemeryck A, De Vriendt C, Belpaire FM. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. Eur J Clin Pharmacol. 1999;54:947-951. (Pubitemid 29104416)
3. Yamazaki H, Shimada T. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochem Pharmacol. 1997;54:1195-1203. (Pubitemid 27497246)
4. Zhou S, Gao Y, Jiang W, et al. Interactions of herbs with cytochrome P450. Drug Metab Rev. 2003;35:35-98. (Pubitemid 36249785)
5. Zou L, Harkey MR, Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 2002;71:1579-1589. (Pubitemid 34808718)
6. Qiu F, Zhang R, Sun J, et al. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos. 2008;36:1308-1314. (Pubitemid 351929315)
7. Izzo AA, Di Carlo G, Borrelli F, et al. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005;98: 1-14. (Pubitemid 40169845)
8. Nutescu EA, Shapiro NL, Ibrahim S, et al. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf. 2006;5:433-451.
9. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2005;65:1239-1282. (Pubitemid 41038418)
10. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57: 1221-1227.
11. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134-138. (Pubitemid 30068565)
12. Samuels N. Herbal remedies and anticoagulant therapy. Thromb Haemost. 2005;93:3-7. (Pubitemid 40124247)
13. Cuzzolin L, Francini-Pesenti F, Zaffani S, et al. Knowledge about herbal products among subjects on warfarin therapy and patient-physician relationship: a pilot study. Pharmacoepidemiol Drug Saf. 2007;16: 1014-1017. (Pubitemid 47422851)
14. Wong RS, Cheng G, Chan TY. Use of herbal medicines by patients receiving warfarin. Drug Saf. 2003;26:585-588. (Pubitemid 36724097)
15. Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239. (Pubitemid 23069000)
16. Macan H, Uykimpang R, Alconcel M, et al. Aged garlic extract may be safe for patients on warfarin therapy. J Nutr. 2006;136(suppl 3): 793S-795S. (Pubitemid 43363777)
17. Lesho EP, Saullo L, Udvari-Nagy S. A 76-year-old woman with erratic anticoagulation. Cleve Clin J Med. 2004;71:651-656. (Pubitemid 39193340)
18. Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf. 1997; 17:342-356. (Pubitemid 27496853)
19. White HD, Gruber M, Feyzi J, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007;167: 239-245.
20. Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther. 2003;10:163-169.
21. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol. 2001;52:587-595.
22. Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium barbarum L. Ann Pharmacother. 2001;35: 1199-1201. (Pubitemid 32959186)
23. Lambert JP, Cormier J. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy. 2001;21:509-512. (Pubitemid 32275282)
24. Makheja AN, Bailey JM. The active principle in feverfew. Lancet. 1981;2: 1054. (Pubitemid 11027603)
25. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother. 1999;33:426-428. (Pubitemid 29215809)
26. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb Haemost. 2002;87:1075-1076. (Pubitemid 34624893)